Brian Calingaert
Impact in
- Obstetrics and Gynecology top 0.5%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
Papers in
-
- Ovarian cancer diagnosis and treatment 23
- Endometriosis Research and Treatment 7
-
- Endometrial and Cervical Cancer Treatments 17
- Co-authors
- Andrew BerchuckJoellen M. SchildkrautSusana Perez‐GutthannDaniel L. Clarke‐PearsonJordi CastellsaguéJohn T. SoperAngeles Alvarez SecordLaura J. Havrilesky
- Journals
- Gynecologic Oncology (12 papers)Pharmacoepidemiology and Drug Safety (11 papers)Drug Safety (4 papers)Cancer Epidemiology Biomarkers & Prevention (4 papers)International Journal of Gynecological Cancer (3 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Brian Calingaert
87 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 134
- Obstetrics and Gynecology 1.2k
- Reproductive Medicine 1.2k
- Pharmacology 484
- Oncology 446
- Genetics 437
Countries citing papers authored by Brian Calingaert
This map shows the geographic impact of Brian Calingaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Calingaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Calingaert more than expected).
Fields of papers citing papers by Brian Calingaert
This network shows the impact of papers produced by Brian Calingaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Calingaert. The network helps show where Brian Calingaert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brian Calingaert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 2 | |
| 3 | 2022 | 5 | |
| 4 | 2021 | 19 | |
| 5 | 2018 | 1 | |
| 6 | Characterization of new users of cilostazol in the United Kingdom, Spain, Sweden, and Germany | 2016 | 1 |
| 7 | 2015 | 24 | |
| 8 | 2011 | 27 | |
| 9 | Evaluation of current risk evaluation and mitigation strategies | 2009 | 1 |
| 10 | 2008 | 56 | |
| 11 | 2008 | 82 | |
| 12 | 2007 | 100 | |
| 13 | 2006 | 28 | |
| 14 | 2005 | 21 | |
| 15 | 2005 | 81 | |
| 16 | 2004 | 0 | |
| 17 | 2003 | 63 | |
| 18 | 2002 | 58 | |
| 19 | 2001 | 48 | |
| 20 | The effect of maternal substance abuse on the cost of neonatal care. | 1996 | 13 |
About Brian Calingaert
Brian Calingaert is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Family Practice, Genetics and Endocrinology, Diabetes and Metabolism, having authored 89 papers that have together received 3.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (17 papers), BRCA gene mutations in cancer (9 papers), Estrogen and related hormone effects (7 papers), Diabetes Treatment and Management (7 papers), Endometriosis Research and Treatment (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). The work is most often cited by research in Obstetrics and Gynecology (1.2k citations), Reproductive Medicine (1.2k citations), Pharmacology (484 citations), Oncology (446 citations) and Genetics (437 citations). Brian Calingaert has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Andrew Berchuck, Joellen M. Schildkraut, Susana Perez‐Gutthann, Daniel L. Clarke‐Pearson, Jordi Castellsagué, John T. Soper, Angeles Alvarez Secord, Laura J. Havrilesky, Nuria Riera‐Guàrdia and Cristina Varas‐Lorenzo. Their work appears in journals such as Gynecologic Oncology, Pharmacoepidemiology and Drug Safety, Drug Safety, Cancer Epidemiology Biomarkers & Prevention and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.